That’s what Swedish scientists claim in a report in The Lancet medical journal. Atenolol is sold under the brand name Tenormin by drugs giant AstraZeneca and is one of the most widely prescribed drugs of its kind but the Swedish researchers question its benefits saying the drug was no better than a placebo in reducing deaths from heart attacks or heart disease.
In one study, the drug did reduce strokes in patients taking it.
But Dr. Bo Carlberg at Norrlands University Hospital in Umeå said, ”The main finding was that atenolol could not be shown to have the same preventive effects on cardiovascular disease as other common anti-hypertension drugs.”
Sweden’s Medical Products Agency is to investigate.